RPG Life Sciences Ltd Share Price

Q: What is the share price of RPG Life Sciences Ltd today?

RPG Life Sciences Ltd share price as on 16 Dec 2025 is ₹2304.0

Pharmaceuticals

NSE: RPGLIFE Small Cap ISIN: INE105J01010

As on 16 December 2025 at 06:21 IST

₹2,304

-12.40

(-0.54%)

Sell Buy

Over 1 Month

-1.66%

Over 6 Months

3.17%

Over 1 Year

1.63%

Over 3 Years

160.78%

RPG Life Sciences Ltd Summary

Close ₹2,316.40

Open ₹2,290

High ₹2,330

Low ₹2,287.80

Volume 5,767

Net Turnover (in Cr) ₹1.34

52Wk High ₹2,725

52Wk Low ₹1,835

52Wk High / Low

1,835

2,725

RPG Life Sciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,831.10

EPS (TTM) 67.39

Book Value (BV) 334.94

Div. Yield 1.04 %

P/E (TTM) 17.72

Price/Book Value 6.89

Delivery % 61.92 %

Face Value 8

Key Ratios

PE Ratio 20.56

PB Ratio 7.10

EV to Sales 5.55

PEG Ratio 0.19

ROA 34.06

ROE 25.53

Debt-Equity -

Net Profit Margin 17.69

Operating Profit Margin 26

RPG Life Sciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	666.11	589.26	517.61	443.15	390.05
Total Expenses	515.83	471.42	425.93	369.98	336.47
Profit Before Tax	232.88	117.84	91.68	73.17	53.58
Profit After Tax	183.24	87.66	67.64	51.48	40
Operating Profit After Depreciation	150.90	118.29	91.99	73.69	54.37

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	183.94	125.06	134.67	109.32	115.63
Total Non Current Assets	192.56	214.78	155.30	137.70	127.54
Total Current Assets	465.25	298.09	264.05	206.91	175.85
Total Assets	657.81	512.87	419.35	344.61	303.39
Total Shareholder's Fund	530.53	374.85	307.60	255.77	216.45

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	77.86	94.36	90.82	64.75	58.27
Net Cash Used In Investing Activities	-41.80	-79.15	-105.81	-34.66	-7.96
Net Cash Used In Financing Activities	-27.08	-20.31	-17.12	-13.51	-10.49

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	181.68	168.92	143.09	172.71	172.21
Total Expenses	142.65	133.45	117.60	123.55	126.28
Profit Before Tax	49.45	35.43	134.90	46.89	15.09
Profit After Tax	36.85	26.29	117.35	34.93	4.20
Operating Profit after Depreciation	43.57	40.70	30.55	52.47	47.87

RPG Life Sciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 2,292.80

S2 2,269.20

S3 2,250.60

Pivot 2,311.40

R1 2,335

R2 2,353.60

R3 2,377.20

Moving Average

20 SMA 2,255.16

50 SMA 2,310.06

100 SMA 2,335.80

200 SMA 2,293.20

RPG Life Sciences Ltd Corporate Actions

RPG Life Sciences Ltd

₹4.0/Share

Announcement Date 27 Jun 2025

Record Date 27 Jun 2025

Div Yield 50%

AGM Date: 31 Aug 2021

This is to inform you that the Fourteenth Annual General Meeting (AGM) of the Members of the Company will be held on Tuesday August 31 2021 at 3.00 p.m. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India inter alia to transact the businesses stated in the Notice convening the said AGM. In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Circular No. 20/2020 dated May 5, 2020 and General Circular No. 02/2021 dated January 13, 2021 issued by the Ministry of Corporate Affairs, we enclose herewith the copies of newspaper advertisements published in today's Business Standard (English) and Mumbai-Lakshadeep (Marathi), intimating inter- alia that Fourteenth Annual General Meeting of the Company will be held on Tuesday, August 31, 2021 at 3.00 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Request you to kindly take the same on record. Pursuant to Regulation 30 read with Para A of Part A in Schedule III of the Listing Regulations we enclose herewith the brief proceedings of the Fourteenth Annual General Meeting (AGM) of the Company held on Tuesday August 31 2021 at 3:00 p.m. as Annexure A. Further pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Companies Act 2013 read with Rule 20 of the Companies (Management and Administration) Rules 2014 we are also submitting herewith the details regarding the voting results of the business transacted at the AGM in the prescribed format along with the Consolidated report of the Scrutinizer as Annexure B and Annexure C respectively. All the resolutions at AGM were passed with requisite majority. You are requested to take the same on record. (As Per BSE Announcement Dated on 8/31/2021 6:00:01 AM) RPG Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 01.09.2021)

AGM Date: 29 Jul 2022

AGM 29/07/2022 The Board of Directors at its meeting held on Friday, April 29,2022 had recommended a final dividend of Rs. 9.60 per equity share of Rs. 8.00 each of the Company for the financial year ended March 31,2022 for approval by the Members at the Fifteenth Annual General Meeting (AGM) scheduled to be held on Friday, July 29, 2022 at 3.00 p.m. (IST) through Video Conferencing (VC)/ Other Audio- Visual Means (OAVM). Other relevant details are being provided in the Notice of AGM, which will be issued in due course of time. (As Per BSE Announcement Dated on 01.07.2022) Pursuant to applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copies of newspaper advertisements published in today's Business Standard (English) and Mumbai-Lakshadeep (Marathi), in compliance with the relevant circulars issued by Ministry of Corporate Affairs from time to time , intimating inter alia that Fifteenth Annual General Meeting of the Company will be held on Friday, July 29, 2022 at 3.00 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Request you to kindly take the same on record. (As Per BSE Announcement Dated on 02.07.2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copy of Notice of 15th Annual General Meeting published in today's newspapers in Business Standard (English) and Mumbai-Lakshadeep (Marathi), as intimation of completion of dispatch of Notice of AGM, and information related to e-voting. Request you to kindly take the same on record. (As Per BSE Announcement dated on 08.07.2022) Pursuant to Regulation 30 read with Para A of Part A in Schedule III of the Listing Regulations, we enclose herewith the brief proceedings of the Fifteenth Annual General Meeting (AGM) of the Company held on Friday, July 29, 2022 at 3:00 p.m. as Annexure A. Further, pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, we are also submitting herewith the details regarding the voting results of the business transacted at the AGM in the prescribed format along with the Consolidated report of the Scrutinizer as Annexure B and Annexure C respectively. All the resolutions at AGM were passed with requisite majority. You are requested to take the same on record. (As per BSE Announcement Dated on 29/07/2022) RPG Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 30/07/2022)

AGM Date: 04 Aug 2023

AGM 04/08/2023 Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed, Friday, July 21, 2023, as the Record Date for determining entitlement of Members to final dividend, if approved by the Members at the AGM. RPG Life Sciences Limited has informed BSE about Notice of Shareholders Meeting for Annual General Meeting. (As Per BSE Announcement Dated on 13.07.2023) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copy of Notice of 16th Annual General Meeting published in today''s newspapers in Business Standard (English) and Mumbai- Lakshadeep (Marathi), as intimation of completion of dispatch of Notice of AGM, and information related to e-voting. Request you to kindly take the same o record. (As Per BSE Announcement dated on 14.07.2023)

AGM Date: 16 Jul 2024

AGM 16/07/2024 Company has hereby informed Exchange about 17th Annual General Meeting scheduled to be held on July 16, 2024. (As Per BSE Announcement dated on 11.06.2024) Brief Proceedings and details of Voting Results of the 17th Annual General Meeting of the Company. (As Per BSE Announcement Dated on: 16/07/2024)

AGM Date: 16 Jul 2025

The Board of Directors at its meeting scheduled on April 28, 2025 had recommended a final dividend of Rs. 20 and additionally a special dividend of Rs.4, aggregating to Rs. 24 per Equity shares of Rs.8 each of the Company for 18th AGM Scheduled on July 16, 2025 fixed the record Friday 27, 2025 The letter in further to our letter dated June 14, 2025, conveying that 18th Annual General Meeting of the Members of the company will be held on Wednesday July 16, 2025 at 3:00 p.m. through Video Conferencing (VC)/ other Audio-Visual Means (OAVM). (As Per BSE Announcement Dated on :23.06.2025) Brief Proceedings and details of voting results of 18th Annual General Meeting of the Company. (As Per BSE Announcement dated on 16.07.2025)

RPG Life Sciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,426.90	₹1,70,614
Torrent Pharmaceuticals Ltd	₹3,789.25	₹1,28,239.68
Cipla Ltd	₹1,517.20	₹1,22,555.05
Dr Reddys Laboratories Ltd	₹1,279.65	₹1,06,803.47

RPG Life Sciences Ltd Top Mutal Funds Invested

Fund Name	AUM
Unifi Flexi Cap Fund	0.91%
Bandhan BSE Healthcare Index Fund	0.07%
Motilal Oswal BSE 1000 Index Fund	0%

RPG Life Sciences Ltd News

RPG Life Sciences schedules board meeting

On 17 October 2025

11 Oct 2025, 10:08 am

RPG Life Sciences to conduct board meeting

On 25 July 2025

19 Jul 2025, 10:29 am

RPG Life Sciences schedules AGM

On 16 July 2025

16 Jun 2025, 03:14 pm

RPG Life edges higher after Q4 PAT rises 64% YoY to nearly Rs 22 crore

RPG Life Sciences advanced 3.79% to Rs 2188.80 after the company reported 64.3% increase in net profit to Rs 21.75 crore in Q4 FY25 from Rs 13.24 crore in Q4 FY25.

29 Apr 2025, 11:35 am

Board of RPG Life Sciences recommends special dividend

Of Rs 4 per share

29 Apr 2025, 09:35 am

RPG Life Sciences Ltd Stock Analysis

Annual revenue for RPG Life Sciences Ltd increased by 13.04% to ₹666.11 crore in FY 2025 from ₹589.26 crore in FY 2024.
Annual Net Profit for RPG Life Sciences Ltd increased by 109.03% to ₹183.24 crore in FY 2025 from ₹87.66 crore in FY 2024.
Promoter Shareholding in RPG Life Sciences Ltd remains unchanged by 0.00% in the most recent quarter, from 72.95% in June 2025 to 72.95% in September 2025.
RPG Life Sciences Ltd delivered a 1-year return of 1.63% compared to the Nifty 50, which provided a return of 6.10% as of the last trading session.
RPG Life Sciences Ltd share price moved down by 0.54% from its previous close of INR ₹2,316.40. The latest RPG Life Sciences Ltd share price is INR ₹2,304.
RPG Life Sciences Ltd share price today has been at a low of 2,175 and a high of 2,312.60. Over the past 52 weeks, the RPG Life Sciences Ltd share price has seen a low of 1,835 and a high of 2,725.